Pereira Renata C, Gitomer Berenice Y, Chonchol Michel, Harris Peter C, Noche Kathleen J, Salusky Isidro B, Albrecht Lauren V
Department of Pediatrics David Geffen School of Medicine at UCL Los Angeles CA USA.
Department of Medicine, Division of Renal Diseases and Hypertension University of Colorado Anschutz Medical Campus Aurora CO USA.
JBMR Plus. 2021 Feb 23;5(4):e10464. doi: 10.1002/jbm4.10464. eCollection 2021 Apr.
Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited cause of chronic kidney disease (CKD) and leads to a specific type of bone disease. The primary cilium is a major cellular organelle implicated in the pathophysiology of ADPKD caused by mutations in polycystin-1 () and polycystin-2 (). In this study, for the first time, cilia were characterized in primary preosteoblasts isolated from patients with ADPKD. All patients with ADPKD had low bone turnover and primary osteoblasts were also obtained from patients with non-ADPKD CKD with low bone turnover. Image-based immunofluorescence assays analyzed cilia using standard markers, pericentrin, and acetylated-α-tubulin, where cilia induction and elongation were chosen as relevant endpoints for these initial investigations. Osteoblastic activity was examined by measuring alkaline phosphatase levels and mineralized matrix deposition rates. It was found that primary cilia can be visualized in patient-derived osteoblasts and respond to elongation treatments. Compared with control cells, ADPKD osteoblasts displayed abnormal cilia elongation that was significantly more responsive in cells with nontruncating mutations and mutations. In contrast, non-ADPKD CKD osteoblasts were unresponsive and had shorter cilia. Finally, ADPKD osteoblasts showed increased rates of mineralized matrix deposition compared with non-ADPKD CKD. This work represents the first study of cilia in primary human-derived osteoblasts from patients with CKD and patients with ADPKD who have normal kidney function, offering new insights as bone disease phenotypes are not well recapitulated in animal models. These data support a model whereby altered cilia occurs in mutated osteoblasts, and that ADPKD-related defects in bone cell activity and mineralization are distinct from adynamic bone disease from patients with non-ADPKD CKD. © 2021 The Authors. published by Wiley Periodicals LLC. on behalf of American Society for Bone and Mineral Research.
常染色体显性多囊肾病(ADPKD)是慢性肾脏病(CKD)最常见的遗传性病因,并会导致一种特定类型的骨病。初级纤毛是一种主要的细胞器,与由多囊蛋白-1()和多囊蛋白-2()突变引起的ADPKD的病理生理学有关。在本研究中,首次对从ADPKD患者分离出的原代前成骨细胞中的纤毛进行了表征。所有ADPKD患者的骨转换率均较低,并且也从骨转换率低的非ADPKD CKD患者中获取了原代成骨细胞。基于图像的免疫荧光分析使用标准标志物、中心体蛋白和乙酰化α微管蛋白对纤毛进行分析,其中纤毛诱导和延长被选为这些初步研究的相关终点。通过测量碱性磷酸酶水平和矿化基质沉积率来检测成骨细胞活性。研究发现,在源自患者的成骨细胞中可以观察到初级纤毛,并且其对延长处理有反应。与对照细胞相比,ADPKD成骨细胞表现出异常的纤毛延长,在具有非截短突变和突变的细胞中反应明显更强。相比之下,非ADPKD CKD成骨细胞无反应且纤毛较短。最后,与非ADPKD CKD相比,ADPKD成骨细胞的矿化基质沉积率更高。这项工作代表了对来自CKD患者和肾功能正常的ADPKD患者的原代人源成骨细胞中纤毛的首次研究,由于动物模型不能很好地再现骨病表型,因此提供了新的见解。这些数据支持了一种模型,即突变的成骨细胞中发生纤毛改变,并且ADPKD相关的骨细胞活性和矿化缺陷与非ADPKD CKD患者的骨动力不足疾病不同。©2021作者。由Wiley Periodicals LLC代表美国骨与矿物质研究学会出版。